Works matching IS 2160763X AND DT 2020 AND VI 9 AND IP 1
Results: 14
Filgotinib, a JAK1 Inhibitor, Has No Effect on QT Interval in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 32, doi. 10.1002/cpdd.755
- By:
- Publication type:
- Article
Possible Contribution of Drug Approval Summaries Published by Drug Regulatory Authorities on Scientific Discussion and Drug Development.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 6, doi. 10.1002/cpdd.744
- By:
- Publication type:
- Article
Phase 1 Dose‐Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Japanese Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 11, doi. 10.1002/cpdd.741
- By:
- Publication type:
- Article
Evaluation of the Pharmacokinetic Interaction Between the Voltage‐ and Use‐Dependent Nav1.7 Channel Blocker Vixotrigine and Carbamazepine in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 62, doi. 10.1002/cpdd.739
- By:
- Publication type:
- Article
Revefenacin, a Long‐Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo‐ and Positive‐Controlled Thorough QT Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 130, doi. 10.1002/cpdd.732
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Insulin Tregopil in Relation to Premeal Dosing Time, Between Meal Interval, and Meal Composition in Patients With Type 2 Diabetes Mellitus.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 74, doi. 10.1002/cpdd.730
- By:
- Publication type:
- Article
Bioequivalence of Ertugliflozin/Metformin Fixed‐Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 50, doi. 10.1002/cpdd.703
- By:
- Publication type:
- Article
First‐in‐Human Study of AG10, a Novel, Oral, Specific, Selective, and Potent Transthyretin Stabilizer for the Treatment of Transthyretin Amyloidosis: A Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Adult Volunteers
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 115, doi. 10.1002/cpdd.700
- By:
- Publication type:
- Article
Effects of Differential Food Patterns on the Pharmacokinetics of Enteric‐Coated Mesalazine Tablets in the Same Cohort of Healthy Chinese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 41, doi. 10.1002/cpdd.696
- By:
- Publication type:
- Article
Dalbavancin Population Pharmacokinetic Modeling and Target Attainment Analysis.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 21, doi. 10.1002/cpdd.695
- By:
- Publication type:
- Article
Safety Profiles, Pharmacokinetics, and Changes in Bone Turnover Markers After Twice‐Weekly Subcutaneous Administration of Teriparatide in Healthy Japanese Postmenopausal Women: A Single‐Blind Randomized Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 87, doi. 10.1002/cpdd.687
- By:
- Publication type:
- Article
Pharmacokinetic Properties of Single and Multiple Doses of Ertugliflozin, a Selective Inhibitor of SGLT2, in Healthy Chinese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 97, doi. 10.1002/cpdd.686
- By:
- Publication type:
- Article
Evaluation of the Pharmacokinetics of Metformin Following Coadministration With Doravirine in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 107, doi. 10.1002/cpdd.685
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 1, doi. 10.1002/cpdd.675
- Publication type:
- Article